Embed Size (px)
Citation preview
annual meetingSNMMI
San Diego, California
JUNE 11-15, 2016
40 Years of FDG in HumansCatch up with the legendary Dr. Abass Alavi
“Countdown Party”This meeting favorite has been revamped for you!
Special SavingsEarly-bird rates are ending soon. See how much you can save!
In This Issue
issue 2
see the savings.Use the Savings!Use the Savings!
see the savings.
Don’t miss your chance to be part of the SNMMI 2016 Annual Meeting—the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging.• NEW! Highlight Country: Japan – spotlighting the latest advances in research, technology,
and clinical practice in Japan.
• NEW! Celebrate 40 Years of FDG in Humans
• NEW! CT Workshop for Technologists – Principles of CT, Anatomy and Case Reviews
• 150+ Expert-Led Scientific and CE Sessions with more than 30 credit hours available
• Emerging Technologies Sessions, including: “The Molecular Imaging and Therapeutics Program Graduates and their Utility in Research Laboratories,” “WMIS/SNMMI Futuristic Nuclear Medicine Technology,” and “Standardization of Advanced PET/SPECT Data Acquisition and Analysis”
Plus, don’t miss: 1,000+ Scientific Posters, the Nuclear Medicine Review Course, Student Technologist Registry Review & Mock Exam, and one of the profession’s largest exhibit halls.
Early-bird Registration Deadline:
April 7, 2016
Register by
Thursday,
April 7th
and save
up to $255.
www.snmmi.org/deadlinewww.snmmi.org/deadline
Save $5 in San DiegoBring this coupon to the SNMMI Booth #1914 during the Annual Meeting and save $5.00* off your purchase.*minimum $10 purchase. Offer valid on new purchases only. Cannot be combined with any other offers.
Four Decades of Unparalleled Impact of FDG-PET Imaging on Research and Practice of Medicine
Celebrating40 Years
of FDG in Humans
Dr. Alavi, as we celebrate the 40th anniversary of FDG in humans, can you tell us about the research that led to the development of FDG?The concept of labeling deoxyglucose (DG) with a positron emitting (PE) radionuclide was first discussed at Penn in 1973 by Abass Alavi, David Kuhl, and Martin Reivich. This discussion was based upon animal research which utilized 14C-DG to image and quantify regional cerebral glucose metabolism by autoradiography. It seemed to us that PE radionuclides would be ideally suited for labeling DG for in-vivo studies. We contacted Alfred Wolf at Brookhaven National Laboratory (BNL), a renowned expert in PE compounds to synthesize 18F-Fluorodeoxyglucose (FDG). Tsuo Ido, a visiting chemist at Wolf’s lab, took a major responsibility for this task. By 1975, FDG was successfully synthesized at BNL. Meanwhile, investigators at Penn had prepared an existing SPECT instrument (Mark IV) for imaging 511 keV x-rays emitted from the positron decay. In August 1976, two normal volunteers were examined by Alavi and the Penn team following the intravenous administration of FDG that was flown from BNL to Philadelphia by air. Images of both subjects showed high concentration of FDG in their brains. One subject was imaged with a whole body, dual-headed scanner. The latter image showed uptake of FDG in the heart and renal excretion. These encouraging results led the group to initiate several larger scale studies.
Tell us a bit about the first human trials?Human trials were initiated by the Penn-BNL team on the East Coast and UCLA team on the West Coast. Meanwhile, specialized PET instruments were designed and built, which allowed generating high resolution images with FDG. Investigators at these sites conducted several exciting projects in multiple CNS disorders. Soon thereafter, the NIH established 5 PET centers that enhanced the prospects for research with this modality. The availability of whole body PET instruments in the 1980’s allowed FDG imaging of other diseases such as cancer. Unfortunately, for a long time, PET imaging was confined to centers that had access to an in-house cyclotron and funding by the NIH. By the late 1990’s, the data from research convinced Medicare about the efficacy of FDG-PET in lung cancer and approval was provided, which was later extended to the other cancers.
In your view, how significant has the use of FDG been in the diagnosis and treatment of patients in the years since the first human trial?The use of FDG-PET for diagnosis, staging, and monitoring response has significantly enhanced medical care for patients with cancer. Also, it has become apparent that FDG-PET is cost-effective and its use has significantly reduced the utility of suboptimal and expensive tests. FDG-PET imaging is among the fastest growing modalities in medicine, and its role has been further enhanced by the introduction of PET-CT and PET-MRI.
What do you see as the future of FDG in the practice of nuclear medicine?It is very clear that FDG-PET as a modality is comparable in importance to major radiological techniques (CT and MRI) and has become an essential pillar in the practice of medicine. In the foreseeable future, FDG-PET will play a critical role in managing many serious diseases. Unfortunately, some of the major applications for FDG (CNS disorders, cancer, myocardial viability, atherosclerosis, infection, inflammation and clot detection) are underutilized at this time and only a fraction of these maladies are being assessed with this technology. My hope is that through funding by the NIH and other agencies, efforts will be made to establish the unquestionable role of FDG-PET in benign disorders and therefore the true impact of this modality will be realized soon.
An Interview with Dr. Abass Alavi about the 40th Anniversary of FDG in Humans
First whole body human FDG scan, August 1976 University of Pennsylvania
t
Abass Alavi, MD
MD (Hon), PhD (Hon), DSc (Hon)
Suddenly, everything else seems vague.
www.milabs.com
Unique high performance adaptive systems with proven resolutions of <0.25 mm in SPECT and <0.75 mm in PET.Unique truly simultaneous PET/SPECT suitable for the largest range of SPECT and PET isotopes (15-600 keV). Unique preclinical quad-modality PET/SPECT/CT/Optical platform fits on just two square meters.
Traditionally, nuclear imaging has always been hampered by limited resolution. MILabs’ versatile high performance molecular imaging solutions set a new standard for molecular imaging research with reliable, compact, multi-modality imaging systems for mice, rats and medium sized animals.
Mouse Cardiac SPECT
Mouse Oncology SPECT
Mouse Knee SPECT
PET, SPECT, CT & Optical MAKING NUCLEAR IMAGING CLEAR
MILabs - SNMMI v1.indd 1 29-1-2016 9:00:26
Brain PET/MRI – Clinical Challenges, Potential, and WorkflowCombined PET/MRI is an emerging hybrid modality for physicians to become aware of and familiar with, as some will eventually incorporate it into their practice. There is significant potential for combined PET/MRI to improve brain imaging in clinical routine. Combined PET/MRI offers several advantages versus software fusion of a separate PET/CT and MRI. This refers to dementias, movement disorders, brain tumors, cerebrovascular disorders, and other neurological conditions. This course aims at providing an overview on the current knowledge about brain PET/MRI in the above applications.
Imaging and Therapy of Neuroendocrine TumorsHistorically misunderstood to be rare and relatively benign, neuroendocrine tumors (NETs) are increasingly common and are now regarded as malignant neoplasms that can cause debilitating symptoms and potentially life-threatening issues for patients. This categorical seminar will present ways that medical oncologists and molecular imaging personnel can collaborate to better image and treat NETs by linking investigational and approved clinical approaches with novel agents that target somatostatin receptors of NETs. Speakers will present how and when to use the imaging and therapeutic components of these agents, along with interpreting the results of the images, combining therapies, and monitoring patients.
Molecular and Multimodality Imaging in Cardiovascular DiseaseThis categorical seminar will introduce you to molecular and multimodality imaging in cardiovascular disease. The seminar will provide basic and relevant information on molecular and multimodality imaging of coronary artery disease (CAD), myocardial perfusion, cardiac sarcoid and amyloidosis, chemotherapy-induced cardiotoxicity, inflammation, device infection and endocarditis. In addition, novel applications of heart failure imaging and imaging targets in heart failure will be addressed.
Molecular Imaging of Cancer Metabolism for the Radiation Therapy PlanningMetabolic reprogramming is considered to be a hallmark of cancer and a potential source of novel targets for diagnostic imaging and therapy in cancer. Imaging informative aspects of metabolism report on biologically and clinically important features of tumor biology, enabling both prognostic counseling and tailoring of therapeutic regimens. Metabolic imaging therefore has the potential to provide a new dimension of precision medicine. A current challenge in molecular imaging is to develop methods to image the large and growing number of metabolic activities shown to function in tumor initiation or progression. This categorical seminar will overview our current understanding of the relationship between oncogenic signaling and tumor metabolism, and the use of emerging techniques in molecular imaging to illuminate key aspects of tumor metabolism in brain cancer and prostate cancer.
Practical PET/CTThis categorical seminar will provide an update on PET/CT, with an emphasis on both basic and clinical knowledge to help meet the needs of those working in clinical practice, and to clarify developments likely to have an impact on the field in the near future. The presenter’s discussion will include protocols (dose reduction, the use of contrast agents, etc.), strategies for dose reduction, NCCN indications for oncologic PET/CT, an update on NaF PET/CT, cardiac PET/CT, and Amyloid brain imaging.
Radionuclide Imaging of Inflammation and Infection: State of the Art and New DevelopmentsThis categorical seminar will provide a comprehensive review of the current status of radionuclide imaging of inflammation and infection, as well as an update on new developments in the field. The seminar will include reviews of currently available single photon - and positron emitting radiopharmaceuticals, as well as developments in imaging of infection with bacteria specific agents and radiolabeled macrophages. Experts in the field will discuss the workup of the patient with fever of unknown origin, musculoskeletal infection, endocarditis and implantable cardiac device infection, and tuberculosis. This seminar will also cover imaging of infection in the pediatric population, imaging inflammation in atherosclerosis & vulnerable plaque, and advances in monitoring response to treatment.
Small Molecule PET RadiotracersThis categorical seminar will review the current state-of-the-art in small molecule PET tracers. The seminar has been designed for those working with any aspect of PET radiotracers (synthesis, R & D, pre-clinical imaging, data analysis, clinical use etc.), and will provide an overview of different types of small molecule PET radiotracers (radiolabeled endogenous molecules, radiolabeled peptides, radiolabeled drug molecules) and their various applications (prosthetic groups, transporter imaging, receptor imaging and imaging of misfolded proteins).
‘Theragnostics’ Beyond Neuroendocrine Tumors: Novel Applications of Targeted Radionuclide Therapy in Malignant and Nonmalignant Conditions.In recent years, a number of new developments in Targeted Radionuclide Therapies using radiolabeled chemical and biological molecules have emerged. This categorical seminar will discuss the use of various radiopharmaceuticals for imaging, and the treatment of both benign and malignant diseases. Various approaches of delivery including monoclonal antibodies, peptides, small molecules, and nanoparticles as well as loco-regional treatment in malignant and non-malignant conditions will be addressed. In addition, the seminar will also cover the status and prospects of Targeted Radionuclide Therapy in children and young adults.
categorical Seminars*
EARLY-BIRD REGISTRATION DEADLINE: APRIL 7, 2016
*Additional fees may apply
physician/scientistFocused Sessions
Career Boot Camp: The Cliff-Note Guide to Navigating Your Career SuccessThe career boot camp is a cliff-notes session designed to address the immediate needs of trainees, junior faculty, and young scientists in the early years of their personal and professional development. The session begins with the ‘day-in-the-life’ introduction to the real-world experiences of scientists in academia, industry, and consulting. Participants will learn how to showcase their skills and ambitions concisely through an effective curriculum vitae.
Brain PET/MRI – Opportunities and ChallengesHybrid PET/MRI systematically offers a complementary combination of two modalities that has often proven itself superior to the single modality approach in the diagnostic work-up of many neurological and psychiatric diseases. In this session, you will introduced to the possible clinical and research applications of this imaging technique. At the end of the session, you will be able to identify typical applications for brain PET/MRI and will have an enhanced understanding about diagnostic advantages in the field of neurdegeneration and neuronocology.
Radium-223 Dichloride Therapy: What We Have Learned Since ALSYMPCARadium-223 dichloride for the treatment of mCRPC has significantly evolved since its clinical approval in the United States in 2013. In this session, you will gain the necessary skills and information to fully and independently manage a patient during a six-treatment course of Radium-223 dichloride, including detection of metastases and evaluation of response to treatment.
Towards Enhanced Prognostic Utility of PET ImagingThis session will provide an overview of the potentials of PET imaging for improved prognostication of different cancer types, utilizing evolving techniques, including alternative image-derived biomarkers and alternative tracers in PET imaging. The session will involve three speakers, focusing on utility of (1) volumetric analysis (beyond conventional SUV analysis), (2) texture/shape/heterogeneity analysis, and (3) use of novel PET imaging methods and tracers for enhanced prognostication.
How to Write Great Grants - Learning How to Shape Your Application to Succeed in Securing FundingThis session will explore helpful hints and how to avoid common pitfalls when grant writing for NIH, DOD, DOE and private foundation. If you are a scientist, pharmacist, or physician interested in enhanc-ing your grant writing skills, this is the session for you.
PET/MR I: Technical AdvancesIn this session, you will review of technical challenges with the development and implementation of PET/MRI. You will focus on the basic concepts in the technology required to make the PET/MRI, as well as new techniques to improve attenuation correction and motion correction in the setting of PET/MRI.
FDG–PET has recently been applied for detection and assessment of cardiac involvement of sarcoidosis. Since cardiac sarcoidosis is a fatal disease, FDG-PET is regarded as an import-ant role for early detection of its disease. In addition, FDG-PET has been used for treatment monitoring of steroid therapy in this disease. For accurate assessment of active involvement of cardiac sarcoidosis, physiological myocardial uptake of FDG should be suppressed. In this joint session, specialists from Japan and USA will discuss optimal patient preparation for FDG-PET, objective assessment of cardiac FDG uptake, and clinical values for diagnosis, treatment monitoring, and patient outcome.
Featured Session: Detection and Assessment of Cardiac Sarcoidosis by FDG-PET
I’m an radiopharmaceutical chemist who makes various things labeled with radiometals and fluorine-18. I had never heard of nuclear medicine before I did a postdoctoral fellowship working in Tc-99 chemistry. I became interested in radiopharmaceutical chemistry because I liked being able to do somewhat more applied research than I had been doing in graduate school.
• How many years have you been attending the SNMMI Annual Meeting?
Since 1986!
• What keeps you coming back? The chance to talk with my friends and colleagues and to see the latest and greatest in radiopharmaceutical chemistry.
• What advice can you give someone who’s attending their first Annual Meeting?
Talk with people! The lectures are great, but the conversations that you have with people will be more in depth.
• What are you most looking forward to in San Diego?
Seeing my friends and colleagues. (Do you detect a theme here?) The opportunity to hear about new research that I wasn’t previously aware of. The chance to visit and explore a beautiful city.
t
Alan B. Packard, PhD Boston Children’s Hospital/
Harvard Medical School
scheduleat-a-Glance
FRIDAY, JUNE 10
8:00 am–6:00 pm CT Workshop for Technologists – Principles of CT, Anatomy and Case Reviews – Day 1
SATURDAY, JUNE 11
7:30–9:30 am Hot Trot 5K Run/Walk
8:00 am–4:00 pm Categorical Seminars
8:30 am–5:30 pm Student Technologist Registry Review – Day 1
9:00 am–5:00 pm Educators Forum I & II
9:00 am–6:00 pm Nuclear Medicine Review Course – Day 1
9:00 am–6:00 pm CT Workshop for Technologists – Principles of CT, Anatomy and Case Reviews – Day 2
9:00 am–6:00 pm SNMMI-TS CE Sessions
4:30–6:00 pm SNMMI CE Sessions
6:00–8:00 pm Welcome Reception: Exhibit and Poster Hall Opening
8:00 pm–End User Meetings
SUNDAY, JUNE 12
6:00–8:00 am User Meetings8:00 am–6:15 pm Nuclear Medicine Review Course – Day 28:30–9:45 am Opening Plenary Session: Henry N. Wagner Jr., MD, Lectureship9:30 am–4:30 pm Exhibit Hall
10:00 am–12:30 pm Emerging Technology Session #110:00 am–8:30 pm Scientific & Educational Poster Hall 10:30–11:00 am SNMMI First Timer’s Orientation10:30–11:30 am Technologist First Timer’s Brunch10:30 am–4:30 pm SNMMI Patient Education Day12:15–2:00 pm Technologist Plenary Session & Awards Recognition12:30–6:00 pm SNMMI CE Courses & Scientific Abstract Presentations1:00–2:30 pm Young Professionals Committee (YPC) Knowledge Bowl2:30–5:30 pm Student Technologist Registry Review – Day 22:45–5:30 pm Educators Forum III2:45–6:00 pm SNMMI-TS CE Courses & Scientific Abstract Presentations4:30–6:00 pm Radiopharmaceutical Sciences Council/CMIIT Basic Science Summary Session4:30–7:00 pm Emerging Technology Session #2 6:00–7:00 pm International Best Abstract Recognition Awards & Reception6:30–8:30 pm RPSC/CMIIT Poster Mixer6:30 pm–End User Meetings
MONDAY, JUNE 13
6:00–8:00 am User Meetings
8:00–9:30 am SNMMI Business Meeting and Special Plenary Session: Cassen Lectureship
8:00 am–12:00 pm JRCNMT Accrediation Seminar
9:00 am–6:00 pm Scientific & Educational Poster Hall
9:30 am–4:30 pm Exhibit Hall
10:00 am–12:30 pm Emerging Technology Session #3
10:00 am–5:45pm SNMMI-TS CE Courses
10:00 am–6:15 pm SNMMI CE Courses & Scientific Abstract Presentations
2:00–3:00 pm Young Investigators Awards (YIA) Ceremony
2:30–4:00 pm “Meet the Author” Session I
3:00–4:30 pm Emerging Technology Session #4
3:00–4:30 pm Computer and Instrumentation Basic Science Summary Session
6:00 pm–End User Meetings
TUESDAY, JUNE 14
6:00–8:00 am User Meetings
8:00 am–6:00 pm CT and MRI Case Reviews – Day 1
8:00 am–6:00 pm SNMMI CE Courses & Scientific Abstract Presentations
9:00 am–6:00 pm Scientific & Educational Poster Hall
9:30 am–3:00 pm Exhibit Hall
10:00 am–5:30pm SNMMI-TS CE Courses
2:45–3:15 pm Scientific Poster Awards
2:45–4:15 pm “Meet the Author” Session II
6:00–9:00 pm User Meetings
9:00 pm–1:00 am “The Countdown Party”
WEDNESDAY, JUNE 15
6:00–8:00 am User Meetings
8:00–9:30 am SNMMI CE Courses
8:00 am–2:45 pm CT and MRI Case Reviews – Day 2
11:30 am–1:15 pm Henry N. Wagner, Jr., MD Highlights Symposium
References: 1. DRAXIMAGE® MAA, Kit for Preparation of Technetium Tc99m Albumin Aggregated Injection [Package Insert]. Kirkland, Québec, H9H 4J4, Canada: Jubilant DraxImage, Inc.; 2011. 2. Data on � le, Jubilant DraxImage, Inc. 3. Parker JA, Coleman RE, Grady E, et al. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol. 2012;40(1):57–65. 4. American College of Radiology. ACR–SPR–STR practice parameter for the performance of pulmonary scintigraphy. Resolution 30. Revised 2014. Available at: www.acr.org/~/media/860d4274393a477daa0d6acf663c9ed8.pdf. Accessed on October 15, 2015.
To get the quality manufactured in here
You need to get the correct particle
count in here1,2
A quality V/Q scan depends on the quality and reliability of DRAXIMAGE® MAA—
from start to � nish
Why you should insist on a particle count of at least 350,000 • Complies with FDA-approved label and the Society of Nuclear
Medicine and Molecular Imaging and American College of Radiology guidelines1,3,4
• Affects how uniformly particles are distributed across the perfused pulmonary vascular bed
• Has been shown to yield good to excellent images2
To learn more, visit us at Booth 1131.
Jubilant DraxImage Inc.16751 Trans-Canada Highway, Kirkland, Québec, Canada H9H 4J4Phone: 1.888.633.5343 / 514.630.7080 Fax: 1.866.431.4288 / 514.694.3865www.draximage.comDRAXIMAGE® is a registered trademark of Jubilant DraxImage Inc. 2016JULUN_2
ALL ATTENDEES WELCOME!Celebrate a successful Annual Meeting…and dance the night away!
Join your colleagues as we countdown to the 2017 Annual Meeting in DenverSponsored by the SNMMI 2016 Annual Meeting Exhibitors
PARTYcountdown“ ”
TUESDAYJUNE 14
9:00PM-1:00AM
Hilton San Diego BayfrontHilton San Diego Bayfront
PARTYcountdown“ ”
la jolla cove
92 golf courses
san diego zoo
balboa park
Summer never ends in San Diego. San Diego
MEETMEINSANDIEGO.COM
Visit MeetMeinSanDiego.com for your free San Diego visitor guide.
Come for the convention,
Stay for the vacation
Come for the Annual Meeting
Stay for the Vacation
Nuclear Medicine and NeurologyThis full day session will focus on the nuclear medicine and PET applications in neurologic imaging. This educational session is geared toward the technologist interested in learning the role nuclear medicine and PET can play in imaging a multitude of neurologic disorders.
Cardiac PETThis session will explain the roles and potentials of Cardiac PET in the physiologic assessment of coronary artery disease. Intended for both technologist and clinician, the course will review the concepts of cardiac PET imaging with focus on utilizing myocardial flow to manage patients.
Leadership Professional DevelopmentIn this session, you’ll learn how leaders in nuclear medicine are born. Featuring three success-ful professionals representing education, clinical management and industry—the speakers will discuss the steps they took to become leaders in the profession. If you’re looking to expand contributions to the field and advance your career; this session will give insight on how to accomplish these goals.
Quality and SafetyIn this session, you’ll focus on patient safety and quality. Held in collaboration with the IAC, NMTCB and ARRT, the session will help you gain a better understanding of how to better utilize CT during patient care studies.
JRCNMT Accreditation WorkshopThis four hour session is intended for program directors of nuclear medicine technology edu-cational programs looking to improve their understanding of, and compliance with JRCNMT accreditation standards and the accreditation process. The course will assist programs directors in writing of the self-study and preparation for the on-site evaluation of the program.
PET/CT, PET/MRI and CT LicensureIn this session, you will review the clinical role of the nuclear medicine technologist (NMT) in PET/MRI, and understand the basic steps required to obtain appropriate credentials in Computed Tomography (CT). This program will include a discussion on the clinical practice of a NMT in PET/MRI and provide a review of the requirements and challenges in obtaining credentials in CT.
• How many years have you been attending the SNMMI Annual Meeting?
I have attended meetings since the late 1990’s
• What keeps you coming back? Attending meetings gives you the opportunity to meet new people as well as see old friends and colleagues from around the country and world, while also allowing you to see what’s new in our field. You never know what doors may open as a result of being at this meeting.
• What advice can you give someone who’s attending their first Annual Meeting?
Make the most of it! There is so much to see and do. Make a plan for what and who you want to see and this will improve your chances of doing so. The meeting goes by so very quickly, before you know it it is over.
• What are you most looking forward to in San Diego?
Catching up with old friends and visiting this beautiful city.
t
Focused Sessions
This case review is designed for the NMT that will be performing CT scanning. CT image processing and display will be examined from acquisition through postprocessing. Patient related factors affecting image quality will be explained, as well as artifact production and reduction. Principles of digital system quality assurance and maintenance will be presented. CT imaging procedures will include indications, patient prep and education, history and contract media usage, and selectable scan parameters for the images. Anatomy and image interpretation will be reviewed. *Additional registration fee
Featured Program: CT Workshop for Technologists – Principles of CT, Anatomy and Case Reviews*
technologist
Ellie Mantel, CNMT, RT(N), FSNMMI-TS Manager, Division of Nuclear Medicine
and Clinical Molecular Imaging Department of Radiology Hospital of the University of Pennsylvania
SNMMI-TS Award Recognition and Plenary SessionCelebrate the outstanding accomplishments over the past year during the SNMMI-TS Awards Recognition Ceremony. Then, stay for the Technologist Plenary Session, focused on patient care.
International Best Abstract Recognition Awards CeremonyMore than 60 countries are represented each year among the scientific abstracts featured at the meeting. This awards ceremony recognizes the best scientific abstract from each submitting country.
Poster Hall MixerThe Radiopharmaceutical Sciences Council (RPSC) and the Center for Molecular Imaging Innovation and Translation (CMIIT) invite you to attend the Annual Poster Hall Mixer. It’s your opportunity to view hundreds of scientific posters, enjoy refreshments, and visit with professional colleagues. The Poster Hall Mixer offers light food and beverages in a social atmosphere to encourage a lively scientific exchange for poster authors and attendees
Student Technologist Registry ReviewAdditional registration fees apply. This course is designed as a review for nuclear medicine technology students and others preparing to sit for the Nuclear Medicine Technology Certification Board (NMTCB) and/or the American Registry of Radiologic Technologists (ARRT) examinations. The course includes an 8-hour review session on Saturday and a mock registry examination on Sunday.
In this presentation Joanna Fowler will describe the development of 18FDG from initial concept through the first successful synthesis and delivery from Brookhaven on Long Island to the University of Pennsylvania for the first
new for 2016!Highlight Country – Japan
As the scope of the SNMMI Annual Meeting continues to expand, so does our enthusiasm to provide attendees with a truly global perspec-tive on the discipline of nuclear medicine and molecular imaging. This year, the Annual Meet-ing will highlight the latest advances in research, technology, and clinical practice in Japan.
As the top international abstract submitting country for each of the past five years, Japan was the perfect choice for this exciting programming addition to the Annual Meeting. Learn more about highlight country programming: www.snmmi.org/japan
Joanna S. Fowler, PhD
Working Against Time: Designing and Synthesizing
FDG for the First Human Studies in 1976
Henry N. Wagner, Jr., MD Lectureship Speaker
Celebrating40 Years
of FDG in Humans
t quantitative human imaging studies in 1976.
programmingspecial
exhibit hallFrom the
t
Christine DempseyHermes Medical Solutions, Inc.
• What’s your name, your company, and what is your role at the organization?
My name is Christine Dempsey. I am the Company Administrator for Hermes Medical Solutions, Inc.
• How many years has your company exhibit-ed at the SNMMI Annual Meeting?
At least since 2001.
• What keeps you coming back? We have always been happy with the quality of attendees choosing to visit our booth. The interaction and potential partnerships with the decision makers is great.
• The size of the Exhibit Hall floor can be daunting for an attendee. What’s your recommended strategy for visiting the 150+ exhibiting companies at the SNMMI Annual Meeting?
It is not something that can be easily done in one day without preparation. The attendee should map out the exhibit hall based on what their needs are. They know their session schedules and should plan a section of the exhibit hall with each break. Trying to see everything at one time could be frustrating.
Exhibit/Poster Hall Opening & Welcome ReceptionThis Saturday evening event is the perfect opportunity to connect with more than 160 companies representing the latest innovations in nuclear medicine and molecular imaging products and services. Plus, take time to explore the hundreds of scientific posters in the Poster Hall, representing notable studies and conclusions in this dynamic field of medicine The Exhibit/Poster Hall will be open from Saturday evening to Tuesday afternoon during the SNMMI Annual Meeting.
Hot Spot - Cash Prize in the Exhibit HallVisit the Exhibit Hall for the chance to win $300 in cash, simply for being in the right booth at the right time! Up to 20 exhibitors will designate their booth as a “Hot Spot.” There will be 2 drawings each day during Dedicated Exhibit Hall Hours. If you’re in a designated Hot Spot booth when Show Management announces the company name and booth number, you’re eligible to win the $300 cash prize!
Providing leaders in the profession with direct access to more than 160 of the top industry suppliers -
that’s the mission of the SNMMI Annual Meeting Exhibit Hall. Explore the latest technologies, witness
ground-breaking new products and services, and connect with the companies that make it happen.
• Absolute Imaging Solutions• ABX Advanced Biochemical Compounds• ABX-CRO advanced pharmaceutical
services• Actinium Pharmaceuticals Inc.• Advanced Accelerator Applications• Advanced Cyclotron Systems, Inc.• Advanced Mobility by Kentucky Trailer• AirNet II LLC• American Board of Nuclear Medicine
(ABNM)• American College of Nuclear Medicine
(ACNM)• American College of Radiology (ACR)• AMICI, Inc.• AnazaoHealth Corporation• ANMI SA• ARRT, The American Registry of
Radiologic Technologists• Associated Couriers, Inc.• Association of Imaging Producers &
Equipment Suppliers (AIPES)• Astellas• Bachem Americas, Inc.• Bayer HealthCare• BC Technical, Inc.• Becquerel & Sievert Co., Ltd• Best Cyclotron Systems• Biodex Medical Systems, Inc.• Blue Earth Diagnostics Limited• Board of Pharmacy Specialties (BPS)• Bracco Diagnostics, Inc.• BTG• Cambridge Isotope Laboratories Inc.• Canadian Association of Nuclear
Medicine (CANM)• Capintec, Inc.• Cardinal Health• Cardiovascular Imaging Technologies• Center of Molecular Research Ltd.• Certus International, Inc.• CheMatech• Chinese Society of Nuclear Medicine• CMR Naviscan Corporation• Comecer Group• Crystal Photonics GmbH• Cubresa Inc.• Cyclomedica Australia Pty• Cyclomedical International, Inc.• Data Spectrum Corporation• Daxor Corporation• Destaco• Digirad Corporation• Dilon Technologies• DOE Isotope Program• DOSIsoft• ec² Software Solutions
• Eckert & Ziegler Eurotope GmbH• Eckert & Ziegler Isotope Products• Elysia• European Association of Nuclear
Medicine (EANM)• GE Healthcare• Genzyme, a Sanofi Company• Hawaiian Moon• HEPATIQ LLC• HERMES Medical Solutions, Inc.• Hidex Oy• Huayi Isotopes Company• IBA• IBA Molecular/Zevacor Molecular• Imaging Technology News• Intersocietal Accreditation Commission
(IAC)• IntraMedical Imaging• INVIA Medical Imaging Solutions• inviCRO• Ionetix Corporation• IQ Medical Services• IRE Elit• isoSolutions Marketing & Management
Inc.• ISO-TEX Diagnostics, Inc.• IsoTherapeutics Group, LLC• ITG Isotope Technologies Garching
GmbH• iThera Medical• Ivy Biomedical Systems• Japanese Society of Nuclear Medicine• Jubilant DraxImage, Inc.• KEOSYS• LabLogic Systems Limited• Lantheus Medical Imaging, Inc.• Lilly USA, LLC.• M&I Materials• Macrocyclics• Mallinckrodt Pharmaceuticals• Marquis Medical, LLC.• MarShield - Division of MarsMetal• Medi/Nuclear Corporation, Inc.• MedImage, Inc.• Mediso Medical Imaging Systems Ltd.• MiE America• MILABS BV• MIM Software Inc.• Mirada Medical• MOLECUBES NV• Molecular Dynamics• MR Solutions Ltd.• Navidea Biopharmaceuticals• NorthStar Medical Radioisotopes, LLC• Nuclear Medicine Technology
Certification Board (NMTCB)• Numa Inc.
• ORA (Optimized Radiochemical Applications)
• PerkinElmer Inc.• Perma-Fix Medical, S.A.• Pharmalucence• Philips• Photo Diagnostic Systems, Inc.• Pinestar Technology, Inc.• Piramal Imaging• PMOD Technologies Ltd.• Posi-Med LLC• Progenics• QC1• Radiation Shielding Inc.• RadioMedix Inc.• Rotem Industries• Scintomics GmbH• SEDECAL• Segami Corporation• Siemens Healthcare• Sirtex Medical, Inc.• SNMMI• SNMMI Development• Sofie Biosciences, Inc.• Southern Scientific• Spectrum Dynamics Medical, Inc.• Spectrum Pharmaceuticals, Inc.• Springer• Sumitomo Heavy Industries, Ltd.• SynterMed, Inc.• Synthra GmbH• Taiyo Nippon Sanso Corporation• Tema Sinergie S.p.A.• The Education and Research Foundation
for Nuclear Medicine and Molecular Imaging (ERF)
• The Gollman Group• Thinking Systems Corporation• ThyCa: Thyroid Cancer Survivors’
Association, Inc.• Toshiba America Medical Systems, Inc.• Trasis SA• Triad Isotopes, Inc.• TriFoil Imaging• Tru-Motion Products• UltraSPECT Inc.• Uniteko Co., Ltd• Universal Medical Resources, Inc.• UPPI LLC• USC Molecular Imaging Center• Von Gahlen International• Waters Corporation• West Physics• Wolters Kluwer• World Molecular Imaging Society
(WMIS)
*As of March 1, 2016
SNMMI 2016 Annual Meeting San Diego, CA
Hotel Amenities
Hot
el M
ap L
ocat
or
Sgl/D
bl/D
bl-D
bl
Res
taur
ants
Fitn
ess
Cen
ter (
fee
may
app
ly)
Bus
ines
s C
ente
r
Swim
min
g Po
ol (I
ndoo
r/Out
door
)
Roo
m S
ervi
ce
Com
p B
reak
fast
Dis
tanc
e to
San
Die
go C
onve
ntio
n C
ente
r (B
lock
s)
Dis
tanc
e to
San
Die
go A
irpor
t (M
iles)
Airp
ort S
huttl
e Pr
ovid
ed b
y th
e ho
tel (
fee
may
ap
ply)
AA
A / F
orbe
s R
atin
g
Che
ck In
/Out
Courtyard San Diego Downtown 1 $249 1 Yes Yes No Yes No 8 3 No 3 3:00PM/12:00PMEmbassy Suites San Diego Bay - Downtown 2 $259 2 Yes Yes Indoor Yes Yes 5 2.5 No 3 4:00PM/12:00PMHard Rock Hotel San Diego 3 $259 2 Yes Yes Outdoor Yes No 1 3.4 No 4 4:00PM/11:00AM
Hilton San Diego Bayfront (HQ) 4 $279 4 Yes Yes Outdoor Yes No 1 3 No 4 3:00PM/12:00PMHilton San Diego Gaslamp Quarter Hotel 5 $269 1 Yes Yes Outdoor Yes No 1 5 No 3 3:00PM/12:00PMHorton Grand 6 $199 1 No Yes No Yes No 3 3.6 No 3 3:00PM/12:00PMHotel Solamar 7 $219/$229 1 Yes Yes Outdoor Yes No 3 2.9 No 4 3:00PM/12:00PMManchester Grand Hyatt San Diego 8 $271 7 Yes Yes Outdoor Yes No 2 1 No 4 4:00PM/12:00PMMarriott Marquis San Diego Marina 9 $278 4 Yes Yes Outdoor No No 1 3.3 No 4 4:00PM/12:00PMOmni San Diego Hotel 10 $249 1 Yes Yes Outdoor Yes No 2 3 No 4 3:00PM/12:00PM
Residence Inn San Diego Downtown/Gaslamp Quarter 11$230 1 Yes Yes Outdoor No Yes 2.5 3.8 No 3 4:00PM/12:00PM
San Diego Marriott Gaslamp Quarter 12
$229 1 Yes Yes No Yes No 2 4 No 4 4:00PM/12:00PMThe Westin San Diego 13 $258.00 1 Yes Yes Outdoor Yes No 5 2.3 Yes 4 3:00PM/12:00PMWyndham San Diego Bayside 14 $194.00 3 Yes Yes Outdoor Yes No 10 1.5 Yes 3 3:00PM/12:00PM
*The Marriott Marquis and Marina Hotel will provide complimentary internet access for attendees booked within the SNMMI room block provided the attendee is a Marriott Rewards member or becomes one at check-in. Any guest that is not a Marriott Rewards member will be charged $1.00 per room, per day, if utilized.
hotel Information
GO
LDFI
NC
H
SLOAN AVE.
MEW
SWASHINGTON
PENNSYLVANIA AVE.
ROBINSON AVE.
7TH
AV
E.
8TH
AV
E.
ESSEX ST.
ROBINSON AVE.
PENNSYLVANIA AVE.VER
MO
NT
10TH
PL. H
ERB
ERT
CEN
TRE ESSEX ST.
PENNSYLVANIACRESENT CT.
BUSH
CR
AN
E
HA
WK
IBIS
PIO
NEE
R
DA
NA
PENN
SYLV A
163
CONVENTION WAY PARK BLVD.
PARK BLVD.
16TH ST.
LOGAN AVE.
HARBOR DR.
E ST.
1ST
AVE
.
2ND
AV
E.
3RD
AV
E.
4TH
AV
E.
5TH
AV
E.
6TH
AV
E.
7TH
AV
E.
8TH
AV
E.
9TH
AV
E.
F ST.
G ST.
E ST.
F ST.
G ST.
J ST.
K ST.
L ST.
KE
TTN
ER
BLV
D.
PAC
IFIC
HW
Y.
DATE ST.
ELM
FIR ST.
GRAPE ST.
GRAPE ST.
FIR ST.
ELM ST.
DATE ST.
A ST.
B ST.
C ST.
BROADWAY
MARKET ST.
ISLAND AVE.
CEDAR ST.
BEECH ST.
IND
IA S
T.
CO
LUM
BIA
ST.
STA
TE S
T.
UN
ION
ST.
FRO
NT
ST.
10TH
AV
E.
19TH
AV
E.
20TH
AV
E.
21S
T AV
E.
19TH
AV
E.
IMPERIAL AVE.
COMMERCIAL ST.
17TH
AV
E.
16TH
AV
E.
15TH
AV
E.
14TH
AV
E.
13TH
AV
E.
20TH
AV
E.
21S
T AV
E.
22N
D A
VE
.
11TH
AV
E.
PAR
K B
LVD
.
ASH ST.
HA
RB
OR
DR
.
DATE ST.
SAN D IEGO
CONVENT ION CENTER
LITTLEITALY
SANTA FETRAIN DEPOT
HORTON PLAZA
GASLAMPQUARTERGASLAMPQUARTER
PETCOPARK
SAN DIEGO INTERNATIONAL AIRPORT U.S. NAVALHOSPITAL
BALBOAPARK
CRUISE SHIPTERMINAL
BROADWAY PIER
USS MIDWAY
EMBARCADEROMARINA PARK NORTH
EMBARCADEROMARINA PARK SOUTH
SEAPORTVILLAGE
THE HEADQUARTERS
EMBA
RCAD
ERO
GRAPE STREET PIER
FERRYLANDING
5
163
V i s i t s a n d i e g o . c o m
1 Courtyard San Diego Downtown 10 14
2 Embassy Suites San Diego Bay - Downtown
5 9
3 Hard Rock Hotel San Diego Across the street
1
4 Hilton San Diego Bayfront (HQ) Adjacent 1
5 Hilton San Diego Gaslamp Quarter Across the street
1
6 Horton Grand 4 7
7 Hotel Solamar 4 5
8 Manchester Grand Hyatt San Diego 2 6
9 Marriott Marquis San Diego Marina Adjacent 1
10 Omni San Diego Hotel Across the street
2
11 Residence Inn San Diego Downtown/Gaslamp Quarter
2 6
12 San Diego Marriott Gaslamp Quarter
2 5
13 The Westin San Diego 10 15
14 Wyndham San Diego Bayside 17 22
hotels Blockswalking time
(in min.) From sDcc
mts/san diego tRoLLeY LinecoasteR/amtRaK Line
inteRnationaL VisitoR inFo. centeRsan diego conVention centeR
8
9
4
10
1
2
5
67
1112
13
14
3
June 11-15, 2016San Diego Convention Center
Society of Nuclear Medicine and Molecular Imaging
V TE YES ON MEMBERSHIP
The clear choice for nuclear medicine professionals:
www.snmmi.org/2vote
The clear choice for nuclear medicine professionals:The Society of Nuclear Medicine and Molecular Imaging
More than 50 years experience#1 advocate for your professionFree CE credit to maintain your professional standingLive events on both the local and national levelThe latest coding and reimbursement resources
SAVE ON YOUR ANNUAL MEETING REGISTRATION!
registration
Pre-Meeting Categorical Seminars - (Requires an additional fee unless you are a weekend attendee)See page 5 for listings: Saturday, June 11 | Member Fee: $150 | Nonmember Fee: $200
Specialty WorkshopsNew! CT Workshop for Technologists – Principles of CT, Anatomy and Case ReviewsFriday-Saturday, June 10-11, 2016 | | Member Fee: $545 | Nonmember Fee: $595
The Nuclear Medicine Review CourseSaturday-Sunday, June 11-12, 2016 | Member Fee: $200 | Nonmember Fee: $300
The Student Technologist Registry Review and Mock ExamSaturday-Sunday, June 11-12, 2016 | Fee: $50
SNMMI 2016 Virtual MeetingSNMMI Virtual Meeting Online Access Only | Member Fee: $139 | Nonmember Fee: $239SNMMI Virtual Meeting Online Access AND USB | Member Fee: $219 | Nonmember Fee: $319
Registration Type Member Nonmember Member Nonmember Member Nonmember
Physician $665 $1,145 $700 $1,290 $890 $1,400
Scientist $665 $1,145 $780 $1,290 $890 $1,400
Industry $665 $1,145 $780 $1,290 $890 $1,400
Technologist $390 $655 $450 $705 $550 $805
Laboratory Professional* $420 $685 $485 $795 $595 $905
Emeritus – Physician/Scientist $315 n/a $320 n/a $460 n/a
Emeritus – Technologist $195 n/a $215 n/a $315 n/a
Resident and Student** $205 $330 $230 $380 $340 $490
Technologist Student** No Charge $75 No charge $105 No charge $205
Companion/Guest (16 yrs or older) $50 $50 $50
Regular Meeting Registration† (Saturday – Wednesday)
Regular RegistrationRates (on/before June 9)
Early-Bird Registration Rates
(on or before April 7)
Onsite Registration Rates(beginning June 10)
*Laboratory Professionals must provide written verification. Download a verification form.**Residents and Students (Intern, Scientist In-Training, Medical/Graduate/Technologist Student) must provide written verification on official letterhead signed by Program Director, or Advisor. Technologist Student Fee does not include CE credit. †Regular Registration does not include categoricals or specialty workshops. These events require an additional fee. Weekend registration includes a categorical course with the exception of technologists/technologist students who will receive additional CE course credit beginning Saturday afternoon at 1pm, in place of the eliminated tech categorical.
Registration Cancellation/Change Policy: Cancellation and change request must be received by May 6, 2016 to qualify for a refund less a $75.00 cancellation fee. No refunds will be issued for cancellation and changes received after May May 6, 2016. Refunds will be processed based on the original form of payment within 30 days after the completion of the meeting. No shows will be charged the full registration fee. No refunds will be given for any reason after June 30, 2016.
1850 Samuel Morse DriveReston, VA 20190-5316
www.snmmi.org/deadline
Register by Thursday, April 7th and save
up to $255.
early-birdregistration
deadline:April 7, 2016 Be part of the SNMMI 2016
Annual Meeting—the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging.
